Lupin Limited has informed the Exchange regarding a press release dated Jun 02, 2021, titled "Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application.".
Lupin Limited has informed the Exchange regarding a press release dated Jun 02, 2021, titled "Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application.".